Search Results : DkxSh-003-L Num PRODUCTS MATCHED : 1

Product - please click for more details Brand Cat No Size Price (£)
Donkey anti-sheep IgG (H&L), F(ab)'2 Fragment DyLight 800-Conjugate min x- w/Human, Mouse, Rabbit IgG ImmunoReagents DkxSh-003-L800NHSX 0.5 mg £282.00
Please sign in or sign up to order this product online.
Product Detail: Donkey anti-sheep IgG (H&L), F(ab)'2 Fragment DyLight 800-Conjugate min x- w/Human, Mouse, Rabbit IgG
Product Type: Secondary Antibodies
Format: Lyophilized
Data Sheet: PLEASE CLICK HERE TO DOWNLOAD
Keywords: DkxSh-003-L800NHSX, anti-Sheep IgG
Reactivity: Sheep
Concentration: 1.0 mg/ml (E 1% at 280 nm = 13.0)
Conjugate: DyLight® 800 (Ex = 770 nm; Em = 794 nm)
Purification: Affinity purified using solid phase Sheep IgG
Purity: > 90% based on SDS-PAGE Small amounts of intact IgG may be present.
Host: Donkey
Immunogen: Purified Sheep IgG, whole molecule
Buffer: 10 mM Sodium Phosphate, 0.15 M Sodium Chloride, pH 7.2, 1 % (w/v) BSA, Protease/IgG free
Preservative: 0.05% (w/v) Sodium Azide
Storage: Store freeze-dried powder at 2-8°C.
Shelf Life: 1 year from date of receipt. Prepare working dilution prior to use and then discard.
Specificity: Based on IEP, this antibody reacts with: · heavy (γ) chains on Sheep IgG · light chains on all Sheep immunoglobulins
Cross Reactivity: Based on IEP, no reactivity is observed to: · non-immunoglobulin Sheep serum proteins · IgG from Human, Mouse, or Rabbit
Country Of Origin: Donkey serum was obtained from healthy animals of US origin and under the care of a registered veterinarian.
Disclaimer: For in vitro Laboratory Use Only. Not for diagnostic or therapeutic use. Not for human or animal consumption. Suggested applications of our products are not recommendations to use our products in violation of any patent or as a license under any patent of ImmunoReagents, Inc. Product may not be resold or modified for resale without prior written approval of ImmunoReagents, Inc.
Trademark: DyLight® is a trademark of Thermo Fisher Scientific, Inc. and its subsidiaries.